뒤로
SinoMab BioScience Limited(03681.HK) 가격
03681.HK 주가 차트
SINOMAB BIO-B (03681.HK)
SinoMab BioScience Limited
HK$1.44
-6.49%
$-0.1
장 종료: Jan 16, 16:00:00 HKT
아직 데이터 없음Earnings FAQ
03681.HK의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
SinoMab BioScience Limited 03681.HK의 지난 분기 매출 실적은 어땠나요?
SinoMab BioScience Limited의 매출 추정치는 얼마인가요?
SinoMab BioScience Limited의 수익 품질 점수는 얼마인가요?
SinoMab BioScience Limited는 언제 수익을 보고하나요?
SinoMab BioScience Limited의 예상 수익은 얼마인가요?
SinoMab BioScience Limited은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$1.54
시가
$1.54
일일 범위
$1.44 - $1.54
52주 범위
$0.8 - $3.76
거래량
4.2M
평균 거래량
5.9M
EPS(TTM)
-0.16
배당수익률
--
시가총액
$1.9B
SINOMAB BIO-B란 무엇인가요?
SinoMab Bioscience Ltd. is a clinical stage biopharmaceutical company, which engages in the research, development, and manufacture of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody-based biologics. The company employs 61 full-time employees The company went IPO on 2019-11-12. The firm primarily develops mAb-based biologics and new chemical entities (NCE) and its product SM03 is a mAb for the treatment of rheumatoid arthritis (RA). The firm is also developing drugs such as SM17, which has the potential to treat atopic dermatitis (AD), asthma, idiopathic pulmonary fibrosis (IPF) and other immune diseases, and SN1011, which targets systemic lupus erythematosus (SLE), pemphigus, multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD).